1 documents found
Information × Registration Number 0309U003760, 0105U002091 , R & D reports Title Amultinational, multicenter, randomized, doubleblind, parallel group, placebo-controlled clinical trial to investigate safety and efficacy of tibolone ( Org OD14) in women with climacteric symptoms and a history of breast cancer (BC). popup.stage_title Дослідження ефективності та безпечності тіболону у жінок з клімактеричними симптомами і раком молочної залози в анамнезі. Head Hotko Evgen Stepanovych, Registration Date 02-07-2009 Organization Uzhgorod National University popup.description2 According to results of investigation (analysis of climacteric symptoms and their intensity and time to progression) researched agent figured out to be much worse due to negative adverse event (frequency of cervical carcinoma beginnings) that was more often in patients who received research agent with breast cancer in anamnesis than in group of comparison. Product Description popup.authors popup.nrat_date 2020-04-02 Close
R & D report
Amultinational, multicenter, randomized, doubleblind, parallel group, placebo-controlled clinical trial to investigate safety and efficacy of tibolone ( Org OD14) in women with climacteric symptoms and a history of breast cancer (BC).
Head: Hotko Evgen Stepanovych. Amultinational, multicenter, randomized, doubleblind, parallel group, placebo-controlled clinical trial to investigate safety and efficacy of tibolone ( Org OD14) in women with climacteric symptoms and a history of breast cancer (BC).. (popup.stage: Дослідження ефективності та безпечності тіболону у жінок з клімактеричними симптомами і раком молочної залози в анамнезі.). Uzhgorod National University. № 0309U003760
1 documents found

Updated: 2026-03-26


Роздрукувати цю сторінку